Mergers & Acquisitions Mergers & Acquisitions

Illumina gets EU charge sheet for Grail gun-jumping, Commission to seek interim measures

By Natalie McNelis
  • 20 Sep 2021 10:43
  • 04 Oct 2021 09:03
US gene-sequencing company Illumina has received a formal charge sheet concerning the alleged breach of its standstill obligation in its acquisition of cancer-testing company Grail, the European Commission has said. 

The Statement of Objections informs Illumina and Grail that the EU watchdog intends to adopt interim measures to "restore and maintain effective competition" while

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News